Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
COPD (Chronic Obstructive Pulmonary Disease) clinical trials
9 of 10 indexed COPD (Chronic Obstructive Pulmonary Disease) trials are currently recruiting.
10 US clinical trials · 9 currently recruiting
COPD (Chronic Obstructive Pulmonary Disease) is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 9 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is University of Tennessee Graduate School of Medicine, running 1 of these trials.
The research picture
COPD (Chronic Obstructive Pulmonary Disease) has 10 registered US clinical trials, 9 of them open to new participants right now, about 90% of the total.
- 9
- recruiting participants now
- 90%
- of trials open to enrollment
- 2
- in Phase 3–4 (later-stage)
- 1
- top sponsor: University of Tennessee Graduate School of Medicine
Active & Recent Trials
10 total, page 1 of 1
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
AstraZeneca
NCT06283966
Validation of Chronic Obstructive Pulmonary Disease (COPD) Algorithm
Wake Forest University Health Sciences
NCT07223749
Rehabilitation in Safety-net Environments (RISE) to Improve Outcomes in Vulnerable Patients With COPD
University of California, San Francisco
NCT05572632
University of Michigan COPD Identification Through Lung Cancer Screening Cohort Study - MAP2
University of Michigan
NCT07482475
OMEGA - Dietary Intervention - COPD Trial
Johns Hopkins University
NCT05297279
Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
University of Tennessee Graduate School of Medicine
NCT07133880
Evaluation of the Paramedic Evaluation for Acute COPD Exacerbation
University of Massachusetts, Worcester
NCT07072039
Photon-counting CT in Chest Imaging
Duke University
NCT07031336
Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
Bastiaan Driehuys
NCT07037836
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
Generate Biomedicines
NCT07116889
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 1 |
| Phase 3 | 1 |
| Phase 4 | 1 |
Top Sponsors
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Reading the COPD (Chronic Obstructive Pulmonary Disease) Trial Landscape
10 indexed COPD (Chronic Obstructive Pulmonary Disease) studies · 9 recruiting (90%).
Phase mix: 2 late (III/IV) vs 2 early (I/II).
Top sponsor: University of Tennessee Graduate School of Medicine (1 trial), 9 others listed. 10 shown below, recruiting first.
How to read this condition's trial landscape
That ratio is a useful proxy for activity level: a high share of recruiting studies often signals that research interest is current and that new enrollment opportunities are appearing, while a low share typically means the field is dominated by completed or follow-up work where most participant spots have already been filled. These counts reflect the public registry only and include studies at every stage of design, so they should be read as an index of research attention rather than as a measure of treatment availability.
Phase 1 and Phase 2 studies focus on early safety signals, dosing, and preliminary effect, while Phase 3 studies are typically the larger efficacy and safety trials submitted toward regulatory review, and Phase 4 studies follow approved interventions in real-world use. A condition weighted toward later phases often reflects a mature research pipeline with several interventions already close to or past approval, whereas a heavier early-phase tilt suggests the field is still exploring new mechanisms and candidate approaches.
All figures are derived from the public ClinicalTrials.gov dataset maintained by the National Library of Medicine and are reproduced here for reference. Inclusion of a trial, sponsor, or intervention on this page is neither an endorsement nor a recommendation, eligibility, protocol changes, and site-level status can shift frequently, so always verify current details on ClinicalTrials.gov and consult a qualified healthcare provider before acting on anything you see here.
Frequently Asked Questions
How many clinical trials are there for COPD (Chronic Obstructive Pulmonary Disease)?
PlainTrial tracks 10 US clinical trials for COPD (Chronic Obstructive Pulmonary Disease), of which 9 are currently recruiting participants. Data sourced from ClinicalTrials.gov.
How do I find a recruiting trial for COPD (Chronic Obstructive Pulmonary Disease)?
Use the trial list above filtered by "Recruiting" status, or visit our trial finder at /recruiting to search by condition and state. Always discuss trial participation with your healthcare provider before enrolling.
Is this data current?
Data is sourced from ClinicalTrials.gov and reflects our most recent data pull. Trial status may have changed since then. Always verify current information at ClinicalTrials.gov before making decisions about participation.
Related
Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from ClinicalTrials.gov (National Library of Medicine). Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Source: ClinicalTrials.gov (NIH/NLM) ClinicalTrials.gov AACT registry · 2026 Trial counts and statuses sourced from ClinicalTrials.gov. Sponsor counts include both industry and federal/academic sponsors.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page aggregates every registered trial for this condition, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.